Postoperative Complications of Orthopedic Surgery in Patients From High-altitude Regions

October 10, 2024 updated by: Chunling Jiang, West China Hospital

Postoperative Complications of Orthopedic Surgery in Patients From High-altitude Regions: a Cohort Study.

This study will focus on orthopedic surgery patients from high-altitude regions, utilizing smart wearables and monitoring tools to gather perioperative data, including heart rate, oxygen saturation, sleep quality, stress levels, and other relevant metrics. Regular follow-ups will assess recovery and complications, in addition to collecting medical records, lab results, imaging data, and other pertinent records. The ultimate goal is to establish a comprehensive follow-up cohort of orthopedic surgery patients from high-altitude areas.

Study Overview

Status

Not yet recruiting

Detailed Description

Prolonged exposure to hypoxic and low-pressure environments leads to structural remodeling and functional abnormalities in the cardiovascular, respiratory, and hematological systems of high-altitude populations. This elevates the risk of postoperative complications, particularly in patients undergoing orthopedic surgery, significantly impacting their recovery and quality of life. This study will focus on orthopedic surgery patients from high-altitude regions. Using smart wearable devices and other monitoring tools, comprehensive perioperative dynamic data of participants, including heart rate, heart rate variability, oxygen saturation, respiratory rate, sleep quality, activity levels, stress index, and other relevant indicators will be collected. Regular follow-ups will be conducted to evaluate postoperative recovery and monitor the incidence of perioperative complications. Additionally, perioperative data such as electronic medical records, laboratory test results, ECG waveforms, echocardiography, chest CT images, and other pertinent records will be also collected. Through that, this study aims to establish a follow-up cohort of orthopedic surgery patients from high-altitude regions.

Study Type

Observational

Enrollment (Estimated)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients who have lived in high-altitude regions scheduled for orthopedic surgery.

Description

Inclusion Criteria:

  1. Age ≥ 18 years;
  2. ASA classification I-III;
  3. Patients who have lived at an altitude above 2500 meters for more than 6 months ;
  4. Patients scheduled for elective orthopedic surgery.

Exclusion Criteria:

  1. Urgent or emergent surgery;
  2. Expected hospital stay < 48 hours;
  3. Inability to provide informed consent;
  4. Patients who have been out of high-altitude regions for over three months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Orthopedic surgery patients from high-altitude regions
high altitude patients Undergoing orthopedic surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative venous thromboembolism
Time Frame: During hospitalization
Defined according to the European Perioperative Clinical Outcome (EPCO) criteria, including both deep vein thrombosis and pulmonary embolism.
During hospitalization

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative venous thromboembolism
Time Frame: Up to 2 weeks postoperatively
Defined according to the European Perioperative Clinical Outcome (EPCO) criteria, including both deep vein thrombosis and pulmonary embolism.
Up to 2 weeks postoperatively
A composite of postoperative pulmonary complications
Time Frame: During hospitalization
Defined according to the European Perioperative Clinical Outcome (EPCO) criteria, including respiratory infection, respiratory failure, pleural effusion, atelectasis, pneumothorax, bronchospasm, and aspiration pneumonia.
During hospitalization
Postoperative major adverse cardiovascular events
Time Frame: During hospitalization
Defined according to the European Perioperative Clinical Outcome (EPCO) criteria, including non-fatal cardiac arrest, acute myocardial infarction, congestive heart failure, new cardiac arrhythmias, angina, et al.
During hospitalization
Postoperative nausea and vomiting
Time Frame: During hospitalization
Nausea and vomiting
During hospitalization
The quality of postoperative recovery
Time Frame: During hospitalization
Assessed using QoR-15 score at different time points after surgery
During hospitalization
Chronic pain after surgery
Time Frame: Up to 1 year postoperatively
Assessed using NRS scale and BPI at different time points after surgery
Up to 1 year postoperatively
Postoperative quality of life assessment
Time Frame: Up to 1 year postoperatively
Assessed using WHODAS2.0 scores at different time points after surgery
Up to 1 year postoperatively

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain scores of movement-evoked pain
Time Frame: During hospitalization
Assessed using NRS scale and BPI at different time points after surgery
During hospitalization
Pain scores at rest
Time Frame: During hospitalization
Using NRS scale and BPI at different time points after surgery
During hospitalization
Surgical site infection
Time Frame: During hospitalization
Defined according to the European Perioperative Clinical Outcome (EPCO) criteria
During hospitalization
Time of Bowel function recovery
Time Frame: During hospitalization
Defined as time to first defecation or flatus
During hospitalization
Sleep quality after surgery
Time Frame: Up to 1 year postoperatively
Assessed using the Pittsburgh Sleep Quality Index (PSQI) and the Morningness-Eveningness Questionnaire (MEQ) at different time points after surgery
Up to 1 year postoperatively
Postoperative anxiety assessment
Time Frame: Up to 1 year postoperatively
Assessed using GAD-7 scores at different time points after surgery
Up to 1 year postoperatively
Postoperative depression assessment
Time Frame: Up to 1 year postoperatively
Assessed using PHQ-9 scores at different time points after surgery
Up to 1 year postoperatively
Postoperative cognitive function assessment
Time Frame: Up to 1 year postoperatively
Assessed using AD-8 and three-word recall test scores at different time points after surgery
Up to 1 year postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Chunling Jiang, PhD, West China Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 15, 2024

Primary Completion (Estimated)

October 31, 2028

Study Completion (Estimated)

October 31, 2029

Study Registration Dates

First Submitted

October 5, 2024

First Submitted That Met QC Criteria

October 10, 2024

First Posted (Actual)

October 15, 2024

Study Record Updates

Last Update Posted (Actual)

October 15, 2024

Last Update Submitted That Met QC Criteria

October 10, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe